The bispecific HER2/ILR13Rα2 tandem CAR T cells could mitigate antigen escape and improve survival in a GBM PDOX model compared to unispecific CAR T cells, a pool of thereof and a product of T cells co-expressing both CARs [55]. The gene discussed is ERBB2; the disease is glioblastoma.